Subpart H - HEALTH EFFECTS TEST GUIDELINES

Section 799.9110 - TSCA acute oral toxicity
Section 799.9120 - TSCA acute dermal toxicity
Section 799.9130 - TSCA acute inhalation toxicity
Section 799.9135 - TSCA acute inhalation toxicity with histopathology
Section 799.9305 - TSCA Repeated dose 28-day oral toxicity study in rodents
Section 799.9310 - TSCA 90-day oral toxicity in rodents
Section 799.9325 - TSCA 90-day dermal toxicity
Section 799.9346 - TSCA 90-day inhalation toxicity
Section 799.9355 - TSCA reproduction/developmental toxicity screening test
Section 799.9365 - TSCA combined repeated dose toxicity study with the reproduction/developmental toxicity screening test
Section 799.9370 - TSCA prenatal developmental toxicity
Section 799.9380 - TSCA reproduction and fertility effects
Section 799.9410 - TSCA chronic toxicity
Section 799.9420 - TSCA carcinogenicity
Section 799.9430 - TSCA combined chronic toxicity/carcinogenicity
Section 799.9510 - TSCA bacterial reverse mutation test
Section 799.9530 - TSCA in vitro mammalian cell gene mutation test
Section 799.9537 - TSCA in vitro mammalian chromosome aberration test
Section 799.9538 - TSCA mammalian bone marrow chromosomal aberration test
Section 799.9539 - TSCA mammalian erythrocyte micronucleus test
Section 799.9620 - TSCA neurotoxicity screening battery
Section 799.9630 - TSCA developmental neurotoxicity
Section 799.9748 - TSCA metabolism and pharmacokinetics
Section 799.9780 - TSCA immunotoxicity